Aspira Women's Health Inc
F:CUL1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aspira Women's Health Inc
F:CUL1
|
US |
|
N
|
Nankai Chemical Co Ltd
TSE:4040
|
JP |
|
O
|
Orbis Se
XBER:OBS
|
DE |
|
Shikoku Chemicals Corp
TSE:4099
|
JP |
|
MAS Gold Corp
OTC:MSGCF
|
CA |
|
E
|
Enerflex Ltd
F:7EX
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CUL1's stock price target?
Not Available
CUL1 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Aspira Women's Health Inc?
Projected CAGR
59%
Over the last 14 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 6 years is 59%.
What is the Gross Profit forecast for Aspira Women's Health Inc?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 1 year is 3%.